Samira Guennif, Centre d’économie de l’Université Paris Nord (CEPN)
The presentation aims at examining the modalities of IPR strengthening in the South and investigating its influence on public health. Precisely, it intends to specify the great issue in emerging and developing country: ensuring drug accessibility so to reduce the health gap between the North and the South in a context marked by a remarkable reinforcement of intellectual property rights via the ratification of the TRIPS agreement in 1994 and the proliferation of Free trade agreement. To enlighten the threat for public health and drug accessibility in the South, the presentation will discuss IPR reinforcement and effect on public health in the therapeutic field of HIV/AIDS.
About the speaker
Samira Guennif holds a Ph.D in economics. She is Associate professor at the Centre d’économie de l’Université Paris Nord (CEPN) in France. Her researches concern patents, industrial development and public health in developing countries. Precisely, she examines the reinforcement of intellectual property rights and its influence in the developing world in terms of industrial capabilities building in the pharmaceutical sector and access to essential drugs, especially access to antiretrovirals in countries severely hit by the HIV/AIDS epidemic. Her research content case studies from Brazil, India, Thailand and Morocco. Among other, she has co-edited a book entitled “Intellectual property, pharmaceuticals and public health: access to drugs in developing countries” (Edward Elgar publishing). She has also published papers in Research policy, the Journal of health management, the Journal of Intellectual Property Rights, the Asian Journal of WTO and International Health Law and Policy, in Economie et institutions and the Revue Internationale de Droit économique.
Venue: Conference Room
Date: 26 April 2012
Time: 12:30 - 01:30